Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Type 1 Diabetes
Interventions
DEVICE

Extended Wear infusion set

For two of the 4 weeks the Extended Wear insulin infusion set will be used.

DEVICE

Standard Infusion set

For two of the 4 weeks the Standard infusion set will be used

DRUG

Heparin

Trial Locations (1)

94304

Stanford University, Palo Alto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Stanford University

OTHER

NCT02687256 - Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set | Biotech Hunter | Biotech Hunter